bs-006
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2022 (NCT05393440)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05938296 | Phase 1 | Dec 19, 2023 | Binhui Biopharmaceutical Co., Ltd. |
| NCT05393440 | Phase 1 | Jul 1, 2022 | Wuhan Binhui Biotechnology Co., Ltd., Wuhan University, Xiamen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Binhui Biopharmaceutical Co., Ltd. | For profit | 1 | 1 | 1 | 2023 |
| Wuhan Binhui Biotechnology Co., Ltd. | For profit | 1 | 0 | 1 | 2022 |
| Wuhan University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Xiamen University | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1